Apnimed, Inc. (APMD)
14.46
+0.30
(+2.12%)
USD |
NASDAQ |
Nov 06, 10:22
Apnimed EPS Diluted (Quarterly) : 3.025 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.025 |
| March 31, 2026 | 1.700 |
| Date | Value |
|---|---|
| June 30, 2025 | -1.669 |
| March 31, 2025 | -0.7193 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| IGC Pharma, Inc. | -0.0293 |
| Cocrystal Pharma, Inc. | -0.2295 |
| CNBX Pharmaceuticals, Inc. | -0.0001 |
| Arvinas, Inc. | -0.8242 |
| Fulcrum Therapeutics, Inc. | -0.3433 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 126.11M |
| Revenue (Quarterly) | 12.08M |
| Total Expenses (Quarterly) | -114.03M |
| Enterprise Value | 742.98M |
| Gross Profit Margin (Quarterly) | 89.98% |
| Earnings Yield | 16.16% |
| Operating Earnings Yield | 3.96% |
| Normalized Earnings Yield | 16.38 |